These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 19322100)

  • 1. Inverse association between serum concentrations of actin-free vitamin D-binding protein and the histopathological extent of fibrogenic liver disease or hepatocellular carcinoma.
    Gressner OA; Gao C; Siluschek M; Kim P; Gressner AM
    Eur J Gastroenterol Hepatol; 2009 Sep; 21(9):990-5. PubMed ID: 19322100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Questioning the role of actinfree Gc-Globulin as actin scavenger in neurodegenerative central nervous system disease: relationship to S-100B levels and blood-brain barrier function.
    Gressner OA; Schifflers MC; Kim P; Heuts L; Lahme B; Gressner AM
    Clin Chim Acta; 2009 Feb; 400(1-2):86-90. PubMed ID: 19000909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of serum percent trisialotransferrin as potential predictive biomarker of hepatocellular dedifferentiation in chronic liver disease.
    Gressner OA; Jafari S; Erkens M; Gao C; Stanzel S; Gressner AM
    Clin Chim Acta; 2009 May; 403(1-2):188-93. PubMed ID: 19281805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High C5a levels are associated with increased mortality in sepsis patients--no enhancing effect by actin-free Gc-globulin.
    Gressner OA; Koch A; Sanson E; Trautwein C; Tacke F
    Clin Biochem; 2008 Aug; 41(12):974-80. PubMed ID: 18538666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of p53 protein in liver and sera of patients with liver fibrosis, liver cirrhosis or hepatocellular carcinoma associated with chronic HCV infection.
    Attallah AM; Shiha GE; Ismail H; Mansy SE; El-Sherbiny R; El-Dosoky I
    Clin Biochem; 2009 Apr; 42(6):455-61. PubMed ID: 19063876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reconstitution of the actin-scavenger system after orthotopic liver transplantation for end-stage liver disease: a prospective and longitudinal study.
    Schiodt FV; Bondesen S; Müller K; Rasmussen A; Hjortrup A; Kirkegaard P; Hansen BA; Tygstrup N; Ott P
    Liver Transpl Surg; 1999 Jul; 5(4):310-7. PubMed ID: 10388504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study.
    Kim HS; Park JW; Jang JS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
    J Clin Gastroenterol; 2009; 43(5):482-8. PubMed ID: 19197197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevation of serum type IV collagen in liver cancer as well as liver cirrhosis.
    Hong WS; Hong SI; Park SY; Son Y; Lee YS; Chung YH; Yang SK; Suh DJ; Min YI
    Anticancer Res; 1995; 15(6B):2777-80. PubMed ID: 8669863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of determining a protein induced by vitamin K absence in detection of hepatocellular carcinoma.
    Cui R; Wang B; Ding H; Shen H; Li Y; Chen X
    Chin Med J (Engl); 2002 Jan; 115(1):42-5. PubMed ID: 11930656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In situ expression patterns of melanoma inhibitory activity 2 in healthy and diseased livers.
    Hellerbrand C; Bataille F; Schlegel J; Hartmann A; Mühlbauer M; Schölmerich J; Büttner R; Hofstädter F; Bosserhoff AK
    Liver Int; 2005 Apr; 25(2):357-66. PubMed ID: 15780062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Actin-free Gc globulin: a rapidly assessed biomarker of organ dysfunction in acute liver failure and cirrhosis.
    Antoniades CG; Berry PA; Bruce M; Cross TJ; Portal AJ; Hussain MJ; Bernal W; Wendon JA; Vergani D
    Liver Transpl; 2007 Sep; 13(9):1254-61. PubMed ID: 17763400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum insulin-like growth factor I evaluation as a useful tool for predicting the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a prospective study.
    Mazziotti G; Sorvillo F; Morisco F; Carbone A; Rotondi M; Stornaiuolo G; Precone DF; Cioffi M; Gaeta GB; Caporaso N; Carella C
    Cancer; 2002 Dec; 95(12):2539-45. PubMed ID: 12467068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hepatic resection for hepatocellular carcinoma--results and analysis of the current literature].
    Neeff H; Makowiec F; Harder J; Gumpp V; Klock A; Thimme R; Drognitz O; Hopt UT
    Zentralbl Chir; 2009 Apr; 134(2):127-35. PubMed ID: 19382043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic role of serum glypican-3 in differentiating hepatocellular carcinoma from non-malignant chronic liver disease and other liver cancers.
    Tangkijvanich P; Chanmee T; Komtong S; Mahachai V; Wisedopas N; Pothacharoen P; Kongtawelert P
    J Gastroenterol Hepatol; 2010 Jan; 25(1):129-37. PubMed ID: 19793164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiopoietin-2 serum levels are elevated in patients with liver cirrhosis and hepatocellular carcinoma.
    Scholz A; Rehm VA; Rieke S; Derkow K; Schulz P; Neumann K; Koch I; Pascu M; Wiedenmann B; Berg T; Schott E
    Am J Gastroenterol; 2007 Nov; 102(11):2471-81. PubMed ID: 17581268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of the potential association of vitamin D binding protein with lipoproteins.
    Speeckaert MM; Taes YE; De Buyzere ML; Christophe AB; Kaufman JM; Delanghe JR
    Ann Clin Biochem; 2010 Mar; 47(Pt 2):143-50. PubMed ID: 20144976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of circulating activin-A as a serum marker of hepatocellular carcinoma.
    Pirisi M; Fabris C; Luisi S; Santuz M; Toniutto P; Vitulli D; Federico E; Del Forno M; Mattiuzzo M; Branca B; Petraglia F
    Cancer Detect Prev; 2000; 24(2):150-5. PubMed ID: 10917135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum C-reactive protein levels predict survival in hepatocellular carcinoma.
    Nagaoka S; Yoshida T; Akiyoshi J; Akiba J; Torimura T; Adachi H; Kurogi J; Tajiri N; Inoue K; Niizeki T; Koga H; Imaizumi T; Kojiro M; Sata M
    Liver Int; 2007 Oct; 27(8):1091-7. PubMed ID: 17845537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gc-globulin in liver disease.
    Schiødt FV
    Dan Med Bull; 2008 Aug; 55(3):131-46. PubMed ID: 19232164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.